We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 21-40 of 10,000 results
  1. Exploring the inhibitors for competitive AI software development through cloud driven transformation

    COVID-19 has compelled every sector to shift towards virtualizing, and to curb the spread of this deadly virus, technologies like cloud computing,...

    Nitasha Hasteer, Rahul Sindhwani, ... Adityansh Sharma in Annals of Operations Research
    Article 18 October 2023
  2. Thyroid disorders induced by immune checkpoint inhibitors

    Immune checkpoint inhibitors (ICIs) are a revolutionary class of drugs that powerfully contribute to cancer therapy by harnessing the immune system...

    Dimitra Karaviti, Eleni-Rafaela Kani, ... Stavroula A. Paschou in Endocrine
    Article Open access 12 February 2024
  3. The trend of dental check-up and prevalence of dental complications following the use of bone modifying agents in patients with metastatic breast and prostate cancer: analysis of data from the Korean National Health Insurance Service

    Background

    Bone-modifying agents (BMA) are key components in the management of cancer patients with bone metastasis. Despite their clinical benefits,...

    Ah Reum Lim, Wonse Park, ... Soohyeon Lee in BMC Health Services Research
    Article Open access 02 April 2024
  4. Identification of a family of species-selective complex I inhibitors as potential anthelmintics

    Soil-transmitted helminths (STHs) are major pathogens infecting over a billion people. There are few classes of anthelmintics and there is an urgent...

    Taylor Davie, Xènia Serrat, ... Andrew G. Fraser in Nature Communications
    Article Open access 08 May 2024
  5. Inhibitors application time and pasture canopy capture regulate gaseous losses of urine-N

    Technologies have been developed for the in-situ treatment of urine patches deposited by grazing livestock to mitigate nitrogen (N) losses using N...

    Kamal P. Adhikari, Jiafa Luo, ... Donna Giltrap in Nutrient Cycling in Agroecosystems
    Article Open access 07 May 2024
  6. Decoding the conundrum: exploring complex interlinkages between mobile wallet adoption inhibitors among unorganised retailers

    The success of mobile wallet (m-wallet) in develo** countries depends upon a great extent to its adoption among unorganised retailers. The adoption...

    Ashwarya Kapoor, Rajiv Sindwani, Manisha Goel in Journal of Financial Services Marketing
    Article 03 May 2024
  7. Exploring isoindolin-1-ones as potential CDK7 inhibitors using cheminformatic tools

    In women who die from cancer, breast cancer is the most common cause of death. The development of small molecular scaffolds as specific...

    Chahat Arora, Kunal Madaan, ... Ram Singh in In Silico Pharmacology
    Article 04 June 2024
  8. JAK inhibitors improve ATP production and mitochondrial function in rheumatoid arthritis: a pilot study

    Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease associated by inflammation of the synovial tissue and autoantibody production....

    Valentina Mihaylova, Maria Kazakova, ... Victoria Sarafian in Rheumatology International
    Article Open access 20 November 2023
  9. Pre-activation of hypoxia-inducible factor 1-α using prolyl hydroxylase domain inhibitors reduces cisplatin-induced nephrotoxicity

    Cisplatin is a widely used, highly effective chemotherapy drug that has a critical nephrotoxic side effect associated with acute kidney injury....

    Bomin Kim, Soonjo Kwon in Biotechnology and Bioprocess Engineering
    Article 22 June 2024
  10. An Enzymatic Activity Assay for Heparanase That Is Useful for Evaluating Clinically Relevant Inhibitors and Studying Kinetics

    The enzyme heparanase cleaves heparan sulfate and is involved in a range of human diseases including cancer, inflammation, diabetes, and viral...
    Edward Hammond, Vito Ferro in Proteoglycans
    Protocol 2023
  11. A novel compound to overcome influenza drug resistance in endonuclease inhibitors

    Influenza is a seasonal respiratory illness that kills hundreds of thousands of people every year. Currently, neuraminidase inhibitors and...

    Yixin Ren, Li Wan, Shuang Cao in Molecular Diversity
    Article 02 June 2023
  12. Ketones: the double-edged sword of SGLT2 inhibitors?

    Sodium–glucose cotransporter 2 (SGLT2) inhibitors are a class of medications used by individuals with type 2 diabetes that reduce hyperglycaemia by...

    Beatrice C. Lupsa, Richard G. Kibbey, Silvio E. Inzucchi in Diabetologia
    Article 18 October 2022
  13. Identification of inhibitors targeting the energy-coupling factor (ECF) transporters

    The energy-coupling factor (ECF) transporters are a family of transmembrane proteins involved in the uptake of vitamins in a wide range of bacteria....

    Eleonora Diamanti, Paulo C. T. Souza, ... Anna K. H. Hirsch in Communications Biology
    Article Open access 20 November 2023
  14. Potential role of cyclin-dependent kinase 4/6 inhibitors in the treatment of mucosal melanoma

    Mucosal melanoma (MM) is a rare and aggressive form of melanoma with a poorer prognosis compared to other subtypes. Recent large-scale...

    Chaoji Shi, Houyu Ju, ... Guoxin Ren in Holistic Integrative Oncology
    Article Open access 28 May 2024
  15. Binding mechanism and biological effects of flavone DYRK1A inhibitors for the design of new antidiabetics

    The selective inhibition of kinases from the diabetic kinome is known to promote the regeneration of beta cells and provide an opportunity for the...

    Katarzyna Pustelny, Przemyslaw Grygier, ... Anna Czarna in Scientific Reports
    Article Open access 23 October 2023
  16. Assessment of structural and activity-related contributions of various PIM-1 kinase inhibitors in the treatment of leukemia and prostate cancer

    One of the most perilous illnesses in the world is cancer. The cancer may be associated with the mutation of different genes inside the body. The PIM...

    Anushka Sharma, Rahul Dubey, ... Vivek Asati in Molecular Diversity
    Article 20 April 2024
  17. Evaluation of Small-Molecule HDAC Inhibitors Through In Vitro and In Cellulo Approaches

    The aberrant activity of histone deacetylases (HDACs) across a broad range of cancers and other disease indications has led to the development of...
    Nabanita Nawar, Harsimran Kaur Garcha, ... Patrick T. Gunning in HDAC/HAT Function Assessment and Inhibitor Development
    Protocol 2023
  18. Recent Trends in the Development of Corrosion Inhibitors

    The inhibition of aqueous corrosion of metals and alloys is a challenging research area attracting attention from scientists and engineers from...
    M. A. Quraishi, Dheeraj Singh Chauhan in A Treatise on Corrosion Science, Engineering and Technology
    Chapter 2022
  19. Tumor immune checkpoints and their associated inhibitors

    Immunological evasion is one of the defining characteristics of cancers, as the immune modification of an immune checkpoint (IC) confers immune...

    Zerui Gao, **ngyi Ling, ... Aifu Lin in Journal of Zhejiang University-SCIENCE B
    Article 17 October 2022
Did you find what you were looking for? Share feedback.